News that combining chemotherapy with immunotherapy can help extend the lifespan of triple-negative breast cancer patients offers hope for those inflicted with this aggressive and hard-to-treat cancer.
It is a breakthrough for immunotherapy as breast cancer was thought to be unresponsive to the body's immune system.
Please subscribe or log in to continue reading the full article.
Get unlimited access to all stories at $0.99/month
- Latest headlines and exclusive stories
- In-depth analyses and award-winning multimedia content
- Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*
*Terms and conditions apply.